Risk of arterial and venous occlusive events in chronic myeloid leukemia patients treated with new generation BCR-ABL tyrosine kinase inhibitors: a systematic review and meta-analysis.
about
Risk of arterial and venous occlusive events in chronic myeloid leukemia patients treated with new generation BCR-ABL tyrosine kinase inhibitors: a systematic review and meta-analysis.
description
2016 nî lūn-bûn
@nan
2016 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Risk of arterial and venous oc ...... atic review and meta-analysis.
@ast
Risk of arterial and venous oc ...... atic review and meta-analysis.
@en
type
label
Risk of arterial and venous oc ...... atic review and meta-analysis.
@ast
Risk of arterial and venous oc ...... atic review and meta-analysis.
@en
prefLabel
Risk of arterial and venous oc ...... atic review and meta-analysis.
@ast
Risk of arterial and venous oc ...... atic review and meta-analysis.
@en
P2093
P2860
P31
P1476
Risk of arterial and venous oc ...... matic review and meta-analysis
@en
P2093
Carlos Graux
Christian Chatelain
Hélène Haguet
Jean-Michel Dogné
P2860
P356
10.1080/14740338.2017.1261824
P407
P577
2016-11-28T00:00:00Z